Article Versions Notes

Malchiodi ZX, Cao H, Gay MD, Safronenka A, Bansal S, Tucker RD, Weinberg BA, Cheema A, Shivapurkar N, Smith JP. Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment. Cancers. 2021; 13(19):4949. https://doi.org/10.3390/cancers13194949

Malchiodi, Zoe X., Hong Cao, Martha D. Gay, Anita Safronenka, Sunil Bansal, Robin D. Tucker, Benjamin A. Weinberg, Amrita Cheema, Narayan Shivapurkar, and Jill P. Smith. 2021. "Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment" Cancers 13, no. 19: 4949. https://doi.org/10.3390/cancers13194949

Malchiodi, Z. X., Cao, H., Gay, M. D., Safronenka, A., Bansal, S., Tucker, R. D., Weinberg, B. A., Cheema, A., Shivapurkar, N., & Smith, J. P. (2021). Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment. Cancers, 13(19), 4949. https://doi.org/10.3390/cancers13194949